NCT00217698 - Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions

Lung Cancer

Interventions

DRUG

cisplatin

DRUG

gefitinib

DRUG

gemcitabine hydrochloride

Trial Locations (14)

3600

Regionalspital, Thun

8063

City Hospital Triemli, Zurich

CH-4016

Saint Claraspital AG, Basel

CH-4031

Universitaetsspital-Basel, Basel

CH-3010

Inselspital Bern, Bern

CH-4101

Kantonsspital Bruderholz, Bruderholz

CH-7000

Spitaeler Chur AG, Chur

CH-1211

Hopital Cantonal Universitaire de Geneve, Geneva

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

CH-4410

Kantonsspital, Liestal

CH-9007

Kantonsspital - St. Gallen, Sankt Gallen

CH-8400

Kantonsspital Winterthur, Winterthur

CH-8008

Klinik Hirslanden, Zurich

CH-8091

UniversitaetsSpital Zuerich, Zurich

All Listed Sponsors

lead

Swiss Cancer Institute

OTHER